unocompetent patients with severe COVID-19, whose bronchoalveolar aspirate grew Aspergillus fumigatus and had a positive serum galactomannan (GM) antigen. Antinori et al. 8  evidenced the pathological pulmonary alterations postmortem and confirmed the infective Aspergillus via molecular